UK Fibromyalgia Sufferers Petition the National Health Service to Integrate and Pay for BioElectronics’ ActiPatch® Therapy

FREDERICK, MD, USA, November 26, 2014 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer and healthcare medical devices announced today that Pifflers United Chronic and Invisible Illnesses Support Community, www.facebook.com/PifflersUnited, is petitioning the United Kingdom’s NHS’ National Institute for Health & Care Excellence (NICE) for new guidelines for effective Fibromyalgia pain management … Continue Reading

PIFFLERS UNITED – “SUPPORTING ANYONE LIVING WITH CHRONIC/INVISIBLE ILLNESS” REPORTS ACTIPATCH® BIOELECTRONIC THERAPY RELIEVES CHRONIC PAIN IN FIBROMYALGIA

Devon, United Kingdom – Pifflers United Chronic and Invisible Illnesses Support Community, www.facebook.com/PifflersUnited announced the release of results of a study of ActiPatch®, a new bioelectronic pain therapy device, in the self-management of fibromyalgia pain. The results demonstrated that when used in the area of worst pain, very significant clinically meaningful pain reduction can be … Continue Reading

BioElectronics Changing Chronic Pain Treatments

EVP Dr. Deepak Kotak to Address the OTC Pharma Asia Conference FREDERICK, MD, USA, November 5, 2014 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer and healthcare medical devices announced today that its Executive Vice President, Dr. Deepak Kotak has been invited to present BioElectronics’ innovative chronic pain therapy at the OTC … Continue Reading

Chronic Pain Sufferers Confirm BioElectronics’ ActiPatch® Therapy Provides Life Changing Pain Relief

FREDERICK, MD, USA, October 27, 2014 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced drug-free consumer medical devices, today released updated results of its “Try It and Tell Us” 7-day ActiPatch sample program for United Kingdom and Ireland residents who were surveyed about their experience. The data now includes responses from 856 consumers … Continue Reading

Facebook Survey Shows UK Consumers Experience 52% Reduction in Intractable Chronic Pain with ActiPatch® Therapy in Musculoskeletal Pain

FREDERICK, MD, USA, August 26, 2014 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced drug-free consumer medical devices, today released the updated results of its “Try It and Tell Us” 7-day ActiPatch sample program for United Kingdom and Ireland residents who were surveyed about their experience. Overall results for chronic musculoskeletal pain showed … Continue Reading

BioElectronics EVP Dr. Deepak Kotak Interviewed on CEO Live

Dr. Kotak Shares BioElectronics Opportunities in New Markets   FREDERICK, MD, USA, August 19, 2014 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices said that its EVP Dr. Deepak Kotak was interviewed by CEOLIVE.TV as part of its Executive Interview Series. The entire interview is available at http://ceolive.tv/bioelectronics-corp-otc-biel/biel-videos/2282-ceolive-tv-interview-bioelectronics-corp-otcqb-biel In the … Continue Reading

BioElectronics President Letter to Shareholders

August 4, 2014 Dear BIEL Shareholders: BioElectronics Corporation’s mission is to change the way people heal and relieve their pain.  As the chart below, that clearly demonstrates that, we have done exactly that. Chronic pain sufferers in the United Kingdom said that ActiPatch reduced their pain by more than 50%.  This is what the BioElectronics … Continue Reading

ActiPatch® Compared to IcyHot® Smart Relief™ TENS (Transcutaneous Electrical Nerve Stimulator) Technology for Pain Relief

Some of our shareholders have asked about how our products differ from the widely advertised product, IcyHot® Smart Relief™ Pain Relief TENS manufactured by the large European pharmaceutical Sanofi (33 billion annual sales).  This is very good news and illustrates a positive sign of the change in the industry approach to pain control.  A pharma … Continue Reading

BioElectronics “Try It and Tell Us” Facebook Social Media Program Builds Momentum and User Testimonials

UK Consumers Report ActiPatch® Therapy Reduces Pain, Including Fibromyalgia, Without Drugs FREDERICK, MD, USA, June 30, 2014 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced drug-free consumer medical devices, today announced positive early feedback from its “Try It and Tell Us” social media program in the United Kingdom that has attracted thousands of followers.  The … Continue Reading

BioElectronics Device Alleviates Dental Surgical Trauma

New study shows RecoveryRx®  reduces pain and inflammation and accelerates healing FREDERICK, MD, USA, March 25, 2014 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices, announced today that Dr. Bartolomeo Operti MD, Chief of Anesthesia Department Day Hospital Section of Maria Adelaide Hospital and Dr. Tiziano Tealdo, Clinical Instructor at … Continue Reading